FlightPath Biosciences, Inc. — Form D
FlightPath Biosciences, Inc. of Birmingham, MI, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-15. The offering totals $8.0M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-15
- Form: D
- Accession: 0001809914-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $1.1M
- Remaining: $6.9M
- Investors: 6
- Date of first sale: 2023-02-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473544
Issuer
- Name: FlightPath Biosciences, Inc.
- CIK: 0001809914
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 15 Fairfax Street, Birmingham, MI, 48009
- Phone: 415-530-1828
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mark de Souza | Director | Hingham, MA |
| Curtis Scribner | Director | Birmingham, MI |
| Matthew Tindall | Director | Birmingham, MI |
| Matthew Tindall | Executive Officer | Birmingham, MI |
| Cristina Larkin | Director | Birmingham, MI |
| Curtis L Scribner | Executive Officer | Berkeley, CA |
| Matthew Charles Tindall | Director | Berkeley, CA |
| Matthew Charles Tindall | Executive Officer | Berkeley, CA |
| Jayakumar Charles Rajadas | Director | Berkeley, CA |
| Mark P de Souza | Director | Emeryville, CA |
| Mark P de Souza | Executive Officer | Emeryville, CA |
Other filings by this issuer (3)
More